First population study of GM mosquitoes highlights difficulties facing malaria control techniqueFebruary 18, 2003The first laboratory population study of genetically modified mosquitoes identifies issues that need to be faced in the task of turning mosquitoes from disease carriers into disease fighters. Scientists from Imperial College London report in Science today that populations including genetically modified mosquitoes quickly lose their test marker gene when they are bred with unmodified mosquitoes. The scientists say their results have several lessons for further work on developing GM mosquitoes, and they suggest a number of ways around the problems they have observed. With no immediate prospects of a vaccine against the disease that affects more than 300 million people every year, novel strategies to tackle malaria are keenly sought. One strategy is to release a strain of mosquito into the wild that has been genetically engineered so it cannot transmit the malarial parasite. Since the first GM mosquito was created three years ago at Imperial, scientists considering this approach have been examining the evidence from carefully-contained laboratory tests of how transgenic mosquitoes fare when mixed with populations of unmodified mosquitoes. This study, which was funded by the Wellcome Trust, indicates that while the act of modifying mosquitoes does not have a major effect on their ability to survive, when the modified insects are placed in a natural population they have relatively low competitiveness. Professor Andrea Crisanti of the Department of Biological Sciences, and senior author of the paper said: "These population studies are absolutely critical to the regulatory processes that will assess the safety and environmental consequences of this new technology." "They will help to assess the overall feasibility and costs of using GM mosquitoes to fight diseases such as malaria, yellow fever and dengue and play an important part in developing future strategies to banish these major scourges afflicting humanity. "While more work is needed on the molecular genetics of this problem, an increasingly important challenge is to study the population biology of transformed mosquitoes and understand how a beneficial gene can be driven through a wild population," he said. The researchers used a stable and proven gene transfer technology to insert a green or red fluorescent marker into four different lines of the mosquito Anopheles stephensi, the major carrier of malaria in India. In control population studies containing GM mosquitoes only, the fluorescent marker was maintained intact and passed on for over 30 generations. But when the GM insects were allowed to breed with unmodified mosquitoes the number of marker-carrying mosquitoes in the population decreased sharply, and in some experiments the marker disappeared entirely within 4-16 generations. Professor Charles Godfray, Director of the Natural Environment Research Council (NERC) Centre for Population Biology at Imperial, and co-author of the study, carried out mathematical modelling of the mosquito population dynamics. This allowed the researchers to explore the different processes that might explain the performance of GM mosquitoes in a mixed population. The authors suggested reasons for the poor performance of the mosquitoes carrying the inserted marker gene. "By creating a strain of GM mosquitoes through breeding descendants of a single transformed individual, the introduced gene is likely to become associated with one or more deleterious mutations. Though these deleterious genes do not kill the GM mosquito, they cause it to lose out in competition with normal mosquitoes. The good news is that now we have identified these problems they can be mitigated by using crossing regimes that minimise the effects of inbreeding," said the authors. Imperial College, University of London |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles Measuring and modeling blood flow in malaria When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||